Obagi Medical Products, Inc. (Obagi) is a specialty pharmaceutical company that develops, markets and sells, and is a provider of, topical aesthetic and therapeutic prescription-strength skin care systems and related products in the physician-dispensed market. Obagi systems and products are designed to prevent and improve the common and visible skin disorders in adult skin, including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, facial redness, and soft tissue deficits, such as fine lines and wrinkles. Obagi sells its products through a direct sales force in the United States and internationally through distribution partners in over 43 countries across North America, Central America, Europe, the Middle East and Asia. In April 2013, Valeant Pharmaceuticals International Inc acquired the entire share capital of Obagi Medical Products Inc.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:OMPI
CUSIPN/A
Phone+1-562-6281007
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
Obagi Medical Products (NASDAQ:OMPI) Frequently Asked Questions
What is Obagi Medical Products' stock symbol?
Obagi Medical Products trades on the NASDAQ under the ticker symbol "OMPI."
Has Obagi Medical Products been receiving favorable news coverage?
Media stories about OMPI stock have trended somewhat positive on Tuesday, according to Accern Sentiment Analysis. Accern identifies positive and negative news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Obagi Medical Products earned a news and rumor sentiment score of 0.02 on Accern's scale. They also gave media headlines about the specialty pharmaceutical company an impact score of 45.58 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term. View Recent Headlines for Obagi Medical Products.
How do I buy shares of Obagi Medical Products?
Shares of OMPI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Obagi Medical Products?
Obagi Medical Products' mailing address is 50 Technology Drive, IRVINE, CA 92618, United States. The specialty pharmaceutical company can be reached via phone at +1-562-6281007.
MarketBeat Community Rating for Obagi Medical Products (NASDAQ OMPI)
MarketBeat's community ratings are surveys of what our community members think about Obagi Medical Products and other stocks. Vote "Outperform" if you believe OMPI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OMPI will underperform the S&P 500 over the long term. You may vote once every thirty days.
